CB
This company develops small molecules and AI-driven platforms to enhance biomanufacturing processes across various modalities. Their technology boosts T cell expansion for therapeutics and optimizes host cell productivity for recombinant protein and AAV production. They offer on-demand access to their virtual cell modeling platform to rapidly generate and refine molecules for improved yield and quality.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- ChemT Biotechnology is pioneering the use of small molecules to enhance the manufacturing process of immune cell therapies, achieving a 5-10x increase in yield while improving product quality. This approach addresses the high production costs and inconsistent quality that currently plague the cell and gene therapy industry.